Bananas may help lower blood pressure due to their high potassium content, which supports kidney function by promoting sodium ...

A decision is expected in the fourth quarter of 2025.

The FDA has freed Amgen’s mysterious early-stage obesity asset from a clinical hold, with the phase 1 study now enrolling ...

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

The Task Force assembles leading Texas nephrologists, nurses, dietitians, educators, and other CKD experts to review the minimum practice standards data from state agency programs, health systems, and ...

Orphan drug specialist Amicus Therapeutics is paying Dimerix $30 million cash for U.S. rights to the phase 3 prospect DMX-200 ...

Hardworking Tennesseans have tried changes to diets and exercise to lose weight and maintain healthy lifestyles, but ...

The research on metformin and human longevity is scant, but that hasn’t stopped some people from experimenting with it.

The drug enhances outcomes in a high-risk patient population with a significant unmet need. Tirzepatide significantly ...

The pharma will pay $800 million for the biotech, which was launched nearly two decades ago by Alnylam and Ionis to advance ...

Fibrate therapy may lower the risks of mortality and progression to end-stage kidney disease (ESKD), despite raising the risk for new onset stage 3 or higher chronic kidney disease (CKD), a new study ...

Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...